Optical Coherence Tomography Biomarkers in Acute Central Serous Chorioretinopathy: Relationship Between Subretinal Fluid Height and Logmar Visual Acuity
DOI:
https://doi.org/10.37762/jgmds.13-3.824Keywords:
Visual Acuity (VA),, Sub Retinal Fluid (SRF) Height, Pigment Epithelial Detachment, Pigment Epithelium Bumps, Central Serous, Chorioretinopathy, LogMAR Visual Acuity, Optical Coherence TomographyAbstract
ABSTRACT
OBJECTIVES
To evaluate the clinical significance of specific spectral-domain optical coherence tomography (SD-OCT) features, specifically subretinal fluid (SRF) height and retinal pigment epithelial (RPE) alterations, in predicting visual acuity (VA) outcomes in patients presenting with acute central serous chorioretinopathy (CSCR).
METHODOLOGY
This cross-sectional study, conducted at the Department of Ophthalmology, Hayatabad Medical Complex, Peshawar, evaluated 50 consecutive patients with acute CSCR. The sample size was statistically powered to detect a moderate-to-strong correlation (r ≥ 0.39). Maximum subretinal fluid (SRF) height was measured quantitatively. Qualitative parameters included the frequency and location of pigment epithelial detachments (PEDs) and retinal pigment epithelium (RPE) bumps. Snellen VA was converted to continuous LogMAR units for parametric analysis. Relationships were evaluated using Pearson correlation coefficients (r).
RESULTS
The study population comprised 50 male patients with a mean age of 36.50 ± 7.42 years (SD) (range: 25-50 years). A strong, statistically significant positive correlation was observed between maximum SRF height and degraded visual acuity (r = 0.907, P < 0.001). Patients with minimal SRF height (0–200 µ, n=29, 58%) maintained baseline LogMAR vision between 0.00 and 0.30, whereas the maximum recorded SRF height (933 µ) corresponded to a severe visual reduction (LogMAR > 1.30). Concurrently, PEDs were identified in 40% (n=20) of the cohort (28% single, 12% multiple; 14% subfoveal, 26% extrafoveal), and RPE bumps were noted in 64% (n=32). No statistically significant correlation was identified between visual impairment and the presence (r = 0.063, P = 0.666), frequency (r = 0.074, P = 0.608), anatomical site (r = 0.074, P = 0.607) of PEDs, or the presence of RPE bumps (r = 0.024, P = 0.807).
CONCLUSION
In acute CSCR, visual acuity degradation is primarily driven by the physical height of subretinal fluid accumulation beneath the fovea. Secondary microstructural modifications of the RPE such as isolated pigment epithelial detachments or fine RPE contour irregularities show no immediate statistical correlation with baseline visual acuity within this cohort size.
Downloads
Metrics
References
Nkrumah G, Paez-Escamilla M, Singh SR, Rasheed MA, Maltsev D, Guduru A, et al. Biomarkers for central serous chorioretinopathy. Ther Adv Ophthalmol. 2020;12:2515841420950846. doi:10.1177/2515841420950846. PMID: 32952883 DOI: https://doi.org/10.1177/2515841420950846
Mohabati D, van Dijk EHC, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, et al. Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clin Ophthalmol. 2018;12:2167-2176. doi:10.2147/OPTH.S176885. PMID: 30410394 DOI: https://doi.org/10.2147/OPTH.S174573
Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126-145. doi:10.1111/j.1600-0420.2007.00889.x. PMID: 17854419 DOI: https://doi.org/10.1111/j.1600-0420.2007.00889.x
Rim TH, Kim HS, Kwak J, Lee JS, Kim DW, Kim SS. Association of corticosteroid use with incidence of central serous chorioretinopathy in South Korea. JAMA Ophthalmol. 2018;136(10):1164-1169. doi:10.1001/jamaophthalmol.2018.3612. PMID: 30193203 DOI: https://doi.org/10.1001/jamaophthalmol.2018.3293
Nair U, Ganekal S, Soman M, Nair KGR. Correlation of spectral-domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity. Clin Ophthalmol. 2012;6:1949-1954. doi:10.2147/OPTH.S36435. PMID: 23271964 DOI: https://doi.org/10.2147/OPTH.S38363
Mudvari SS, Goff MJ, Fu AD, McDonald HR, Johnson RN, Ai E, et al. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina. 2007;27(9):1168-1173. doi:10.1097/IAE.0b013e3180dbb64a. PMID: 18046232 DOI: https://doi.org/10.1097/IAE.0b013e318156db8a
Song IS, Shin YU, Lee BR. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;154(2):366-375.e1. doi:10.1016/j.ajo.2012.02.019. PMID: 22652038 DOI: https://doi.org/10.1016/j.ajo.2012.02.031
Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina. 2016;36(1):9-19. doi:10.1097/IAE.0000000000000737. PMID: 26352556 DOI: https://doi.org/10.1097/IAE.0000000000000837
Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82-118. doi:10.1016/j.preteyeres.2015.05.003. PMID: 26028504 DOI: https://doi.org/10.1016/j.preteyeres.2015.05.003
van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770. doi:10.1016/j.preteyeres.2019.07.003. PMID: 31325502 DOI: https://doi.org/10.1016/j.preteyeres.2019.07.003
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Retina. 2019;39(10):1851-1860. doi:10.1097/IAE.0000000000002254 DOI: https://doi.org/10.1097/IAE.0000000000002254
Sly J, Madhavi C, Kumar MA. Visual outcome of central serous retinopathy. Int J Res Med Sci. 2015;3(8):1885-1888. doi:10.18203/2320-6012.ijrms20150306 DOI: https://doi.org/10.18203/2320-6012.ijrms20150296
Jamil AZ, Rahman FU, Iqbal K, Ansari HM, Iqbal W, Mirza KA. Intravitreal bevacizumab in central serous chorioretinopathy. J Coll Physicians Surg Pak. 2012;22(6):363-366. PMID: 22647691
Khalil M, Malik TG, Chaudhary QL, Shafiq MM. Angiographic patterns and tomographic findings in central serous chorioretinopathy revisited. Pak J Med Health Sci. 2015;9(4):1409-1413
Manna A, Kuli JJ. Correlation of spectral-domain optical coherence tomography findings with visual acuity in central serous chorioretinopathy. J Evid Based Med Healthc. 2016;3(84):4560-4564. doi:10.18410/jebmh/2016/963 DOI: https://doi.org/10.18410/jebmh/2016/963
Malik A, Gupta A, Mithal C, et al. Central serous chorioretinopathy: correlation of structural changes on optical coherence tomography with visual outcomes. Delta J Ophthalmol. 2017;18(1):37-43. doi:10.4103/1110-9137.201619 DOI: https://doi.org/10.4103/1110-9173.201619
Pan CK, Vail D, Bhattacharya J, Cao M, Mruthyunjaya P. The effect of obstructive sleep apnea on absolute risk of central serous chorioretinopathy. Am J Ophthalmol. 2020;218:148-155. doi:10.1016/j.ajo.2020.05.034. PMID: 32437786 DOI: https://doi.org/10.1016/j.ajo.2020.05.040
Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115(1):169-173. doi:10.1016/j.ophtha.2007.02.037. PMID: 17445801 DOI: https://doi.org/10.1016/j.ophtha.2007.02.032
Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103-126. doi:10.1016/j.survophthal.2012.07.004. PMID: 23410815 DOI: https://doi.org/10.1016/j.survophthal.2012.07.004
Sartini F, Menchini M, Posarelli C, Casini G, Figus M. Optical coherence tomography biomarkers in central serous chorioretinopathy: a review. Diagnostics (Basel). 2023;13(4):720. doi:10.3390/diagnostics13040720. PMID: 36832234 DOI: https://doi.org/10.3390/diagnostics13040720
Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201-214. doi:10.1111/j.1442-9071.2012.02848.x. PMID: 22882553 DOI: https://doi.org/10.1111/j.1442-9071.2012.02848.x
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sadiqullah Khan, Sumayya Samad, Samiuddin, Siraj Khan

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
















